Valeant Shares Side on Report Ex CEO, Ex CFO Focus of DOJ Criminal Probe


Shares of Valeant Pharmaceuticals (NYSE:VRX) tumbled as much as 6% in late trading on Monday after Bloomberg News reported the company's former CEO and CFO are the subjects of a criminal investigation by the Department of Justice for accounting fraud.

This is a breaking-news story, please check back for updates.